These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6960190)

  • 21. Lactulose (cephulac) in portosystemic encephalopathy.
    Kosman ME
    JAMA; 1976 Nov; 236(21):2444-5. PubMed ID: 989871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifaximine versus neomycin in the treatment of portosystemic encephalopathy.
    Di Piazza S; Gabriella Filippazzo M; Valenza LM; Morello S; Pastore L; Conti A; Cottone S; Pagliaro L
    Ital J Gastroenterol; 1991; 23(7):403-7. PubMed ID: 1742538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Early diagnosis and therapy of hepatic coma in viral hepatitis--theoretical concepts and practical possibilities].
    Baumgarten R; Fengler JD; Markus R
    Z Arztl Fortbild (Jena); 1982 Apr; 76(7):286-8. PubMed ID: 7101985
    [No Abstract]   [Full Text] [Related]  

  • 24. Lactulose in the treatment of acute hepatic encephalopathy.
    Fessel JM; Conn HO
    Am J Med Sci; 1973 Aug; 266(2):103-10. PubMed ID: 4742364
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatic encephalopathy.
    Glouberman S
    Ariz Med; 1977 Dec; 34(12):825-6. PubMed ID: 597069
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hepatic encephalopathy. Physiopathology and treatment].
    Perney P; Pomier-Layrargues G
    Gastroenterol Clin Biol; 1994; 18(12):1069-76. PubMed ID: 7750679
    [No Abstract]   [Full Text] [Related]  

  • 27. Perspectives in hepatic encephalopathy.
    Hoyumpa AM; Schenker S
    J Lab Clin Med; 1982 Oct; 100(4):477-87. PubMed ID: 6126512
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of acute and chronic hepatic encephalopathy in cirrhosis].
    Doffoel M; Bockel R
    Ann Gastroenterol Hepatol (Paris); 1984; 20(3):163-6. PubMed ID: 6529174
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain].
    MMW Fortschr Med; 2004 Jan; 146(5):51. PubMed ID: 15035428
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of hepatic encephalopathy with lactulose].
    Veljkov N; Kulenović S; Borovac N; Rezaković D
    Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful use of vancomycin hydrochloride in the treatment of lactulose-resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():284-6. PubMed ID: 2519078
    [No Abstract]   [Full Text] [Related]  

  • 33. Gastrointestinal transit in cirrhotic patients: effect of hepatic encephalopathy and its treatment.
    Van Thiel DH; Fagiuoli S; Wright HI; Chien MC; Gavaler JS
    Hepatology; 1994 Jan; 19(1):67-71. PubMed ID: 8276369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
    Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatic encephalopathy and mild lack of awareness.
    Braillon A
    Aliment Pharmacol Ther; 2010 Jul; 32(2):310. PubMed ID: 20636631
    [No Abstract]   [Full Text] [Related]  

  • 36. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 37. How to dispel myths in the treatment of hepatic encephalopathy?
    Braillon A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):E1; author reply E2. PubMed ID: 17909528
    [No Abstract]   [Full Text] [Related]  

  • 38. First and second generation non absorbable disaccharides in the treatment of hepatic encephalopathy.
    Capocaccia L; Riggio O; Merli M
    Ital J Gastroenterol; 1990 Dec; 22(6):365-7. PubMed ID: 2131958
    [No Abstract]   [Full Text] [Related]  

  • 39. Spectral analysis of the EEG in hepatic encephalopathy treated with levodopa.
    Yaar I; Shapiro MB; Pottala EW
    Electroencephalogr Clin Neurophysiol; 1981 Dec; 52(6):617-25. PubMed ID: 6172261
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatic coma: theory and therapy. Part II.
    Sorrell MF; Barak AJ
    Nebr Med J; 1976 Jan; 61(1):13-5. PubMed ID: 1246371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.